BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1914556)

  • 1. Cooperation between accessory cells and T lymphocytes in patients with tuberculous pleurisy.
    Kurasawa T; Shimokata K
    Chest; 1991 Oct; 100(4):1046-52. PubMed ID: 1914556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some problems concerning local cellular immunity in tuberculosis].
    Shimokata K
    Kekkaku; 1995 Oct; 70(10):595-600. PubMed ID: 8523853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy.
    Fujiwara H; Tsuyuguchi I
    Chest; 1986 Apr; 89(4):530-2. PubMed ID: 3485515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Commemorative lecture of receiving Imamura Memorial Prize. Analysis of cellular immunity against tuberculosis in man with special reference to tuberculous pleurisy and cytokines].
    Shimokata K
    Kekkaku; 1996 Oct; 71(10):591-6. PubMed ID: 8936994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte proliferation and gamma-interferon production after "in vitro" stimulation with PPD. Differences between tuberculous and nontuberculous pleurisy in patients with positive tuberculin skin test.
    Ribera E; Español T; Martinez-Vazquez JM; Ocaña I; Encabo G
    Chest; 1990 Jun; 97(6):1381-5. PubMed ID: 1971783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro tuberculin reactivity of lymphocytes from patients with tuberculous pleurisy.
    Fujiwara H; Okuda Y; Fukukawa T; Tsuyuguchi I
    Infect Immun; 1982 Feb; 35(2):402-9. PubMed ID: 6976936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy.
    Shimokata K; Saka H; Murate T; Hasegawa Y; Hasegawa T
    Chest; 1991 May; 99(5):1103-7. PubMed ID: 1902158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection.
    Rossi GA; Balbi B; Manca F
    Am Rev Respir Dis; 1987 Sep; 136(3):575-9. PubMed ID: 2443047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
    Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
    Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local cellular immunity in tuberculous pleurisy.
    Shimokata K; Kawachi H; Kishimoto H; Maeda F; Ito Y
    Am Rev Respir Dis; 1982 Nov; 126(5):822-4. PubMed ID: 6293353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-presenting capacity of alveolar macrophages and monocytes in pulmonary tuberculosis.
    Ina Y; Takada K; Yamamoto M; Morishita M; Yoshikawa K
    Eur Respir J; 1991 Jan; 4(1):88-93. PubMed ID: 2026242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta.
    Park JS; Kim YS; Jee YK; Myong NH; Lee KY
    Scand J Immunol; 2003 May; 57(5):463-9. PubMed ID: 12753503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculous infection and biological response in man].
    Shimokata K
    Kekkaku; 2004 Sep; 79(9):541-5. PubMed ID: 15552942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential levels of cytokines and soluble Fas ligand between tuberculous and malignant effusions.
    Cui HY; Zhang Q; Su B; Li W; Tang SJ
    J Int Med Res; 2010; 38(6):2063-9. PubMed ID: 21227011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical immunology of tuberculosis].
    Tsuyuguchi I
    Kekkaku; 1990 Sep; 65(9):591-601. PubMed ID: 2232438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of soluble interleukin-2 receptors in tuberculous pleural effusions.
    Ito M; Kojiro N; Shirasaka T; Moriwaki Y; Tachibana I; Kokubu T
    Chest; 1990 May; 97(5):1141-3. PubMed ID: 2331910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the T-cell subset producing gamma-interferon in tuberculous pleural effusion.
    Shimokata K; Kishimoto H; Takagi E; Tsunekawa H
    Microbiol Immunol; 1986; 30(4):353-61. PubMed ID: 3088399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions.
    Ibrahim L; Salah M; Abd El Rahman A; Zeidan A; Ragb M
    Immunol Invest; 2013; 42(2):122-36. PubMed ID: 23252864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation and potential role of interleukin-32 in tuberculous pleural effusion.
    Wang X; Yang C; Quan C; Li J; Hu Y; Liu P; Guan L; Li L
    Front Immunol; 2024; 15():1342641. PubMed ID: 38803498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of interferon gamma in tuberculous pleural effusion.
    Ribera E; Ocaña I; Martinez-Vazquez JM; Rossell M; Español T; Ruibal A
    Chest; 1988 Feb; 93(2):308-11. PubMed ID: 3123150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.